Literature DB >> 10992372

When is pelvic lymph node dissection necessary before radical prostatectomy? A decision analysis.

M V Meng1, P R Carroll.   

Abstract

PURPOSE: In recent years the role of pelvic lymph node dissection before or at radical prostatectomy has been questioned. We compared the outcome of performing or omitting pelvic lymph node dissection in patients undergoing radical retropubic prostatectomy by formal decision analysis.
MATERIALS AND METHODS: We created a decision tree for patients undergoing radical retropubic prostatectomy that accounts for all possible branch points and outcomes. Outcome probabilities applied to the model were derived from published data. Utility values were determined for each outcome state by a panel of experts. Decision analysis was done using decision analysis computer software. Sensitivity analysis was performed to determine which elements in the model were most important and to calculate threshold values.
RESULTS: Using probability data from the literature and our assigned outcome values, decision analysis initially favored omitting pelvic lymph node dissection. Sensitivity analysis revealed that the threshold values for the incidence of positive lymph nodes and the sensitivity of lymph node dissection and frozen section analysis at which outcomes were equivalent were 18% and 80%, respectively. Analysis was insensitive to the pelvic lymph node dissection complication rate.
CONCLUSIONS: We performed formal decision analysis to determine the incidence of lymph node metastasis below which pelvic lymph node dissection is not warranted at radical retropubic prostatectomy. Our results suggest that lymph node dissection is unnecessary in the subset of patients in which the risk of lymph node involvement is less than 18%.

Entities:  

Mesh:

Year:  2000        PMID: 10992372

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

Review 1.  Is it necessary to do staging pelvic lymph node dissection for T1c prostate cancer?

Authors:  M V Meng; P R Carroll
Journal:  Curr Urol Rep       Date:  2001-06       Impact factor: 3.092

2.  Cost-analysis of staging methods for lymph nodes in patients with prostate cancer: MRI with a lymph node-specific contrast agent compared to pelvic lymph node dissection or CT.

Authors:  Anke M Hövels; Roel A M Heesakkers; Eddy M Adang; Gerrit J Jager; Jelle O Barentsz
Journal:  Eur Radiol       Date:  2004-07-13       Impact factor: 5.315

Review 3.  Sentinel node evaluation in prostate cancer.

Authors:  Ramkishen Narayanan; Timothy G Wilson
Journal:  Clin Exp Metastasis       Date:  2018-09-05       Impact factor: 5.150

4.  The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer.

Authors:  Timothy A Masterson; Fernando J Bianco; Andrew J Vickers; Christopher J DiBlasio; Paul A Fearn; Farhang Rabbani; James A Eastham; Peter T Scardino
Journal:  J Urol       Date:  2006-04       Impact factor: 7.450

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.